Mineralys Therapeutics, Inc.
MLYS • NASDAQ
Mineralys Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jon Congleton, with a market cap of $2.2B.
Market Cap$2.2B
Employees28.0
CEOJon Congleton
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · In 4 weeksQ1 2026
Financials
Mineralys Therapeutics, Inc. FAQ
Common questions about Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026.
Mineralys Therapeutics, Inc. has approximately 28 employees.